Skip Navigation LinksHome > August 2013 - Volume 19 - Issue 4, Multiple Sclerosis > Biomarkers of Alzheimer Disease: Current and Future Applicat...
CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000433295.45962.20
Erratum

Biomarkers of Alzheimer Disease: Current and Future Applications to Diagnostic Criteria

Free Access

The April 2013 issue of Continuum (Dementia, Vol 19, Issue 2) contains an error. The following is a correction for that error.

In the article “Biomarkers of Alzheimer Disease: Current and Future Applications to Diagnostic Criteria” by Reisa Sperling, MD and Keith Johnson, MD (CONTINUUM: Lifelong Learning in Neurology 2013;19:328), the sentence “In longitudinal clinical follow-up of patients with MCI with baseline amyloid PET, approximately half were positive on amyloid imaging (versus only 10% of patients who were negative for MCI) convert to a clinical diagnosis of AD dementia over the course of 1 to 3 years” should read “In longitudinal clinical follow-up of MCI patients with baseline amyloid PET, approximately half of patients with MCI who were positive on amyloid imaging and 10% of patients with MCI who were negative on amyloid imaging convert to a clinical diagnosis of AD over the course of 1 to 3 years.”

The editors regret this error.

Copyright © 2013 by the American Academy of Neurology.

Login